Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 104Stomach Neoplasms 19Inflammatory Breast Neoplasms 12Esophageal Neoplasms 11Triple Negative Breast Neoplasms 6Sarcoma 6Carcinoma, Hepatocellular 5Lymphoma, Large B-Cell, Diffuse 4Liver Neoplasms 4Adenocarcinoma Of Esophagus 4Primary Breast Cancer 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Hemangiosarcoma 3Unspecified Adult Solid Tumor, Protocol Specific 2Testicular Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasm Metastasis 2Malignant mesenchymal tumor 2Lymphoma, B-Cell, Marginal Zone 2Liposarcoma 2Hemangiopericytoma, Malignant 2Gallbladder Neoplasms 2Fibrosarcoma 2Desmoplastic Small Round Cell Tumor 2Chondrosarcoma 2Carcinoma, Ductal, Breast 2Breast Neoplasms, Male 2

Interventions

Carboplatin 171Paclitaxel 129Radiotherapy 119Cisplatin 109Docetaxel 93Gemcitabine 81Erlotinib Hydrochloride 80Pemetrexed 78Bevacizumab 56Etoposide 41pembrolizumab 36Gefitinib 32Vinorelbine 31Topotecan 30Surveys and Questionnaires 29Irinotecan 28Radiosurgery 21Nivolumab 20Drug Therapy 20Magnetic Resonance Spectroscopy 18Cetuximab 18durvalumab 17Early Intervention, Educational 17Blood Specimen Collection 17Surgical Procedures, Operative 16Cyclophosphamide 16Celecoxib 15Ipilimumab 14Immunohistochemistry 14Filgrastim 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lung Neoplasms × Epirubicin × Clear all
NCT00003606 2021-02-21

Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

UNICANCER

Phase 3 Completed
216 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡